Evidence map›Paper›PMID 31985400›Full record

ArticleeLife2020

Deep learning models predict regulatory variants in pancreatic islets and refine type 2 diabetes association signals.

Agata Wesolowska-Andersen, Grace Zhuo Yu, Vibe Nylander, Fernando Abaitua, Matthias Thurner, Jason M Torres, Anubha Mahajan, Anna L Gloyn, Mark I McCarthy

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Modeling islet enhancers using deep learning identifies candidate causal variants at loci associated with T2D and glycemic traits.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Agata Wesolowska-AndersenWellcome Centre for Human Genetics, Oxford, United Kingdom.ORCID 0000-0001-8688-2814
Grace Zhuo YuOxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, United Kingdom.
Vibe NylanderOxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, United Kingdom.
Fernando AbaituaWellcome Centre for Human Genetics, Oxford, United Kingdom.
Matthias ThurnerWellcome Centre for Human Genetics, Oxford, United Kingdom.ORCID 0000-0001-7329-9769
Jason M TorresWellcome Centre for Human Genetics, Oxford, United Kingdom.ORCID 0000-0002-7537-7035
Anubha MahajanWellcome Centre for Human Genetics, Oxford, United Kingdom.
Anna L Gloyn *Wellcome Centre for Human Genetics, Oxford, United Kingdom.ORCID 0000-0003-1205-1844
Mark I McCarthy *Wellcome Centre for Human Genetics, Oxford, United Kingdom.ORCID 0000-0002-4393-0510
Centre for Human Genetics · GBUniversity of Oxford · GB

Funding

Identifying variants causal for Type 2 Diabetes in Major human populationsU01DK085545 · NIDDK · UNIVERSITY OF OXFORD · PI CHAN, JULIANA CN, EBRAHIM, SHAH BRIAN · 2009 to 2013
$2.8M
Integrating genome-scale data to reveal causal mechanisms in type 2 diabetesU01DK105535 · NIDDK · UNIVERSITY OF OXFORD · PI GLOYN, ANNA LOUISE · 2015 to 2019
$1.7M
Medical Research Council MR/L020149/1NIDDK NIH HHS U01 DK085545NIDDK NIH HHS U01 DK105535Wellcome Trust 090532Wellcome Trust 095101Wellcome Trust 098381Wellcome Trust 106130Wellcome Trust 200837Wellcome Trust 200837/Z/16/ZWellcome Trust 203141Wellcome Trust 212259
6 · The paper itself

Abstract

Genome-wide association analyses have uncovered multiple genomic regions associated with T2D, but identification of the causal variants at these remains a challenge. There is growing interest in the potential of deep learning models - which predict epigenome features from DNA sequence - to support inference concerning the regulatory effects of disease-associated variants. Here, we evaluate the advantages of training convolutional neural network (CNN) models on a broad set of epigenomic features collected in a single disease-relevant tissue - pancreatic islets in the case of type 2 diabetes (T2D) - as opposed to models trained on multiple human tissues. We report convergence of CNN-based metrics of regulatory function with conventional approaches to variant prioritization - genetic fine-mapping and regulatory annotation enrichment. We demonstrate that CNN-based analyses can refine association signals at T2D-associated loci and provide experimental validation for one such signal. We anticipate that these approaches will become routine in downstream analyses of GWAS.

Indexed as

Deep LearningModels, TheoreticalSignal TransductionChromatinDiabetes Mellitus, Type 2EpigenomicsGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansIslets of LangerhansPolymorphism, Single NucleotideChromatincomputational biologyconvolutional neural networksdeep learningepigenomicsfine-mappinggeneticsgenomicshumanpancreatic isletssystems biologytype 2 diabetes

Identifiers

PMID31985400
PMCPMC7007221
OpenAlexW2971969289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.